Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

Data as of 3:59pm ET
 +0.25 / +3.13%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Imprimis Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the commercial development of novel drug formulations and proprietary drug delivery vehicles. It focuses on meeting unmet patient needs through the development and commercialization of innovative proprietary sterile and topical drug formulations and technologies that are customized for patients. Its network of innovators includes inventive physicians and pharmacists. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in San Diego, CA.

Contact Information

Imprimis Pharmaceuticals, Inc.
12626 High Bluff Drive
San Diego California 92130
P:(858) 704-4040
Investor Relations:
(858) 704-4587



Other institutional9.02%
Individual stakeholders27.69%
Mutual fund holders1.23%

Top Executives

Mark L. BaumChief Executive Office & Director
Gary W. SeelhorstVice President-Corporate Development
Andrew R. BollVice President-Accounting & Public Reporting
Jen Turbiak CarrollHead-Media Relations
Jeannette V. FilipponeSecretary, Chief Legal Officer & General Counsel

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.